当前位置:首页 - 行情中心 - 东北制药(000597) - 财务分析 - 资产负债表

东北制药

(000597)

  

流通市值:62.94亿  总市值:65.45亿
流通股本:13.74亿   总股本:14.29亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金5,818,314,220.895,651,183,181.944,702,985,424.083,851,532,637.95
应收票据及应收账款2,611,330,450.772,397,220,604.742,724,323,537.982,799,576,254.03
其中:应收票据593,928,203.4583,583,587.31593,404,976.45547,219,591.16
应收账款2,017,402,247.371,813,637,017.432,130,918,561.532,252,356,662.87
预付款项110,445,664.99150,056,969.6658,731,287.7983,655,937.38
其他应收款合计251,507,845.38191,253,188.85207,640,603.85206,864,427.5
存货1,433,135,077.171,364,090,227.711,247,673,911.941,357,231,024.54
合同资产6,939,972.87,092,367.4610,605,095.984,450,697.37
其他流动资产25,631,706.0522,163,503.6431,993,288.7833,180,859.36
流动资产平衡项目0000
流动资产合计10,257,304,938.059,783,060,0448,983,953,150.48,336,491,838.13
非流动资产:
固定资产4,090,522,110.24,224,397,871.434,069,951,695.214,186,657,691.5
在建工程216,903,716.67198,865,519.16414,584,742.84391,209,660.61
使用权资产44,905,190.9453,433,397.6458,130,804.7458,156,032.54
无形资产668,858,927.1681,773,700.33688,866,879.18702,173,439.99
开发支出148,337,927.78142,722,332.74140,160,076.56132,973,691.75
商誉26,118,604.8126,118,604.8126,118,604.8126,118,604.81
长期待摊费用675,688.45745,074.64814,460.83596,541.68
递延所得税资产121,972,503.17128,068,299.04118,805,103.76117,789,230.77
其他非流动资产30,558,650.4834,468,798.3439,196,415.6152,392,541.28
非流动资产平衡项目0000
非流动资产合计5,348,853,319.65,490,593,598.135,556,628,783.545,668,067,434.93
资产平衡项目0000
资产总计15,606,158,257.6515,273,653,642.1314,540,581,933.9414,004,559,273.06
流动负债:
短期借款1,570,629,999.991,290,429,999.991,609,999,999.991,839,999,999.99
应付票据及应付账款5,816,453,856.395,777,647,320.024,864,011,643.694,678,278,194.13
其中:应付票据4,427,259,843.74,379,546,536.533,305,990,619.592,895,116,547.34
应付账款1,389,194,012.691,398,100,783.491,558,021,024.11,783,161,646.79
合同负债79,237,698.6131,168,024.2996,798,766.92100,414,360.39
应付职工薪酬2,385,929.4353,553,942.122,264,561.082,412,108.25
应交税费79,433,740.1590,924,585.2174,746,714.7691,165,307.64
其他应付款合计1,615,490,195.041,466,608,057.231,543,595,470.621,743,059,285.25
应付股利1,597,979.181,597,979.181,597,979.181,597,979.18
一年内到期的非流动负债743,606,520.22746,721,625.2176,821,318.16176,432,978.43
其他流动负债8,201,871.7111,434,480.5810,594,216.098,793,019.75
流动负债平衡项目0000
流动负债合计9,915,439,811.539,568,488,034.648,378,832,691.318,640,555,253.83
非流动负债:
长期借款78,400,000150,000,000740,000,000140,000,000
租赁负债21,742,770.6831,287,024.2130,225,627.0630,892,032.9
递延收益152,946,411.39157,118,947.05163,402,453.99167,697,624.5
递延所得税负债3,147,337.515,217,346.265,287,981.135,287,981.13
其他非流动负债202,800,000202,800,000220,400,000220,400,000
非流动负债平衡项目0000
非流动负债合计459,036,519.58546,423,317.521,159,316,062.18564,277,638.53
负债平衡项目0000
负债合计10,374,476,331.1110,114,911,352.169,538,148,753.499,204,832,892.36
所有者权益(或股东权益):
实收资本(或股本)1,429,103,2651,429,103,2651,434,316,2651,434,316,265
资本公积2,480,888,739.872,467,796,232.362,474,772,216.862,458,210,370.87
减:库存股110,717,740110,717,740137,695,768234,779,188
其他综合收益2,016,867.181,950,394.122,448,750.312,649,288.09
专项储备6,455,322.56,455,322.56,486,882.946,497,303.15
盈余公积180,321,681.95180,321,681.95172,911,034.42172,911,034.42
未分配利润1,070,994,474.821,013,360,613.77881,524,255.84796,630,593.05
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,059,062,611.324,988,269,769.74,834,763,637.374,636,435,666.58
少数股东权益172,619,315.22170,472,520.27167,669,543.08163,290,714.12
股东权益平衡项目0000
股东权益合计5,231,681,926.545,158,742,289.975,002,433,180.454,799,726,380.7
负债和股东权益合计15,606,158,257.6515,273,653,642.1314,540,581,933.9414,004,559,273.06
公告日期2024-04-262024-03-302023-10-272023-08-23
审计意见(境内)标准无保留意见
TOP↑